Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Carotid Stenting without Embolic Protection Increases Major Adverse Events: Analysis of the National Surgical Quality Improvement Program

Carotid Stenting without Embolic Protection Increases Major Adverse Events: Analysis of the... Published April 1, 2021 as 10.3174/ajnr.A7108 ORIGINAL RESEARCH INTERVENTIONAL Carotid Stenting without Embolic Protection Increases Major Adverse Events: Analysis of the National Surgical Quality Improvement Program P. Nazari, P. Golnari, M.C. Hurley, A. Shaibani, S.A. Ansari, M.B. Potts, and B.S. Jahromi ABSTRACT BACKGROUND AND PURPOSE: Published data regarding embolic protection device efficacy is mixed, and its use during carotid ar- tery stent placement remains variable. We, therefore, examined the frequency of embolic protection device use and its association with outcomes after carotid artery stent placement using a national quality improvement data base. MATERIALS AND METHODS: Patients undergoing carotid artery stent placement with or without embolic protection devices were identified in the American College of Surgeons National Surgical Quality Improvement Program data base. The primary outcome was the incidence of major adverse cardiovascular events (defined as death, stroke, or myocardial infarction/arrhythmia) within 30 days. Propensity scoring was used to create 2 matching cohorts of patients using demographic and baseline variables. RESULTS: Between 2011 and 2018, among 1200 adult patients undergoing carotid artery stent placement, 23.8% did not have embolic protection devices. There was no trend toward increased embolic protection device use with time. Patients without embolic protec- tion device use http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Neuroradiology American Journal of Neuroradiology

Carotid Stenting without Embolic Protection Increases Major Adverse Events: Analysis of the National Surgical Quality Improvement Program

Loading next page...
 
/lp/american-journal-of-neuroradiology/carotid-stenting-without-embolic-protection-increases-major-adverse-BL0H8k8qV5
Publisher
American Journal of Neuroradiology
Copyright
© 2021 by American Journal of Neuroradiology
ISSN
0195-6108
eISSN
1936-959X
DOI
10.3174/ajnr.A7108
Publisher site
See Article on Publisher Site

Abstract

Published April 1, 2021 as 10.3174/ajnr.A7108 ORIGINAL RESEARCH INTERVENTIONAL Carotid Stenting without Embolic Protection Increases Major Adverse Events: Analysis of the National Surgical Quality Improvement Program P. Nazari, P. Golnari, M.C. Hurley, A. Shaibani, S.A. Ansari, M.B. Potts, and B.S. Jahromi ABSTRACT BACKGROUND AND PURPOSE: Published data regarding embolic protection device efficacy is mixed, and its use during carotid ar- tery stent placement remains variable. We, therefore, examined the frequency of embolic protection device use and its association with outcomes after carotid artery stent placement using a national quality improvement data base. MATERIALS AND METHODS: Patients undergoing carotid artery stent placement with or without embolic protection devices were identified in the American College of Surgeons National Surgical Quality Improvement Program data base. The primary outcome was the incidence of major adverse cardiovascular events (defined as death, stroke, or myocardial infarction/arrhythmia) within 30 days. Propensity scoring was used to create 2 matching cohorts of patients using demographic and baseline variables. RESULTS: Between 2011 and 2018, among 1200 adult patients undergoing carotid artery stent placement, 23.8% did not have embolic protection devices. There was no trend toward increased embolic protection device use with time. Patients without embolic protec- tion device use

Journal

American Journal of NeuroradiologyAmerican Journal of Neuroradiology

Published: Apr 1, 2021

References